State Sen. Leah Vukmir
Press Release

Vukmir, Rohrkaste lead bipartisan effort to lower drug prices

Bill would allow for pharmacists to switch brand-name biologics for biosimilars

By - Nov 1st, 2017 03:04 pm

MADISON, WIS. — Sen. Leah Vukmir, R–Brookfield, and Rep. Mike Rohrkaste, R–Neenah, unveiled a bipartisan bill Wednesday that would help patients get interchangeable versions of biologic prescription drugs and save them money.

This bill allows pharmacists to substitute biologic drugs approved by the Food and Drug Administration with their generic counterpart, called interchangeable biosimilars. Currently, pharmacists can only substitute generic forms of drugs produced chemically. This bill will now replicate that procedure for biologically created drugs and their biosimilars.

Patients are expected to get an estimated 20-percent savings by purchasing a biosimilar drug, as opposed to the brand-name version.

“Everyone knows that buying generic versions of brand-name prescription drugs can produce significant savings for families and seniors,” said Vukmir, a nurse and chairman of the Senate Health and Human Services Committee. “Now that science allows us to create biosimilar drugs, we need to work to make sure Wisconsinites can get these savings at the pharmacist whenever possible.”

“This bill will help improve healthcare outcomes and use healthcare dollars more efficiently,” Rohrkaste added.

Sen. Tim Carpenter, D–Milwaukee, and Reps. John Spiros, R–Marshfield, and Debra Kolste, D–Janesville, have joined this effort as co-authors.

Biologic drugs have helped improve the quality of life for people with arthritis, cancer, leukemia, MS, diabetes, and epilepsy. Thirty-five states have passed similar laws to help consumers get access to interchangeable biosimilar drugs.

Mentioned in This Press Release

Recent Press Releases by State Sen. Leah Vukmir

Leah Vukmir Issues Call To Action for Wisconsin Voters

"Tammy Baldwin and her extreme left allies are using every smear tactic and despicable trick in an attempt to silence us, beat us and obstruct reforms that will help the American middle class."

Despite Baldwin’s Efforts To Hide It, The Tomah VA Report Became Public

“Senator Baldwin let us down by sitting on the Inspector General’s report that detailed the problems at the Tomah VA that endangered veterans,” said Leah Vukmir campaign manager Jess Ward.

Tammy Baldwin Knew About Tomah And Kept It To Herself

Baldwin also denied a plea from VA whistleblower Ryan Honl to make the report public that would’ve spurred action.

One thought on “Vukmir, Rohrkaste lead bipartisan effort to lower drug prices”

  1. Rita says:

    Thank you! Hope it passes.

Leave a Reply

You must be an Urban Milwaukee member to leave a comment. Membership, which includes a host of perks, including an ad-free website, tickets to marquee events like Summerfest, the Wisconsin State Fair and the Florentine Opera, a better photo browser and access to members-only, behind-the-scenes tours, starts at $9/month. Learn more.

Join now and cancel anytime.

If you are an existing member, sign-in to leave a comment.

Have questions? Need to report an error? Contact Us